Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMARC (Biopharmaceutical Manufacturing and Academic Resource Center) is a non-profit contract development and manufacturing organization (CDMO) owned and operated by Colorado State University (CSU) in Fort Collins, Colorado. Established in 2006, BioMARC specializes in high-containment biologics manufacturing, operating under Biosafety Level 2 (BSL-2) and Biosafety Level 3 (BSL-3) containment, as well as CDC Tier 1 select agent biosecurity conditions. The organization provides phase-appropriate cGMP manufacturing, process and method development, cell and virus banking, and aseptic fill-finish services for vaccines, therapeutics, and diagnostics. BioMARC serves biopharmaceutical companies and government agencies, notably manufacturing medical countermeasures for the U.S. Department of Defense and other global health organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMARC.